Location History:
- Arcadia, CA (US) (2003)
- Irvine, CA (US) (2011)
Company Filing History:
Years Active: 2003-2011
Title: Innovations by Robert Chow in Cord Blood Compositions
Introduction
Robert Chow is a notable inventor based in Irvine, California, recognized for his contributions to the field of hematopoietic stem cell research. He holds three patents that focus on advanced methods for processing umbilical cord blood (UCB) compositions. His work aims to enhance clinical outcomes for patients requiring treatments related to the hematopoietic system.
Latest Patents
Chow's latest patents include innovative methods for creating plasma-depleted, not erythrocyte-depleted, cord blood compositions. These UCB compositions are characterized by having plasma that is substantially depleted while retaining red blood cells. The preparation process combines plasma depletion with cryopreservation, selection, thawing, and transplantation of hematopoietic stem cells. This approach maximizes post-processing cell recovery and post-thaw infusion cell dose, leading to superior clinical outcomes. Additionally, his patents provide methods for treating a variety of malignant and benign diseases associated with the hematopoietic system using these UCB compositions.
Career Highlights
Robert Chow is currently associated with Stemcyte, Inc., where he continues to innovate in the field of stem cell therapies. His work has significantly impacted the way umbilical cord blood is utilized in medical treatments, paving the way for improved patient care.
Collaborations
Chow collaborates with esteemed colleagues such as Richard Tonai and Denis O Rodgerson, contributing to a dynamic research environment focused on advancing hematopoietic stem cell applications.
Conclusion
Robert Chow's innovative work in cord blood compositions exemplifies the potential of scientific research to improve medical treatments. His patents and ongoing contributions to the field highlight the importance of advancements in hematopoietic stem cell therapies.